News

BioIVT to Discuss its Pivotal Role in Liquid Biopsy Research at the AACC Annual Scientific Meeting and Clinical Lab Expo

BioIVT’s standardized collection protocols and diverse donor base help facilitate molecular biomarker validation and ensure their clinical utility.

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will highlight the integral role it is playing in liquid biopsy research at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo. This conference will be held from July 23-27 at the Anaheim Convention Center in Anaheim, CA.

The Health Systems Task Force

The Health Systems Task Force is a public-private strategic partnership, bought together by Sir Pascal Soriot, CEO of Astrazenca, which gathers other CEOs and leaders from key stakeholders such as:

Merck KGaA

Novo Nordisk

Roche

Samsung Biologicals

Sanofi

Karolinska Instituet

National Health Service England

the Sustainable Healthcare Coalition

UNICEF

The University of Pavia

World Health Organizaton (WHO)

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company

Eli Lilly's new Alzheimer Drug Shows Promising Results in Phase III TRAILBLAZER-ALZ 2 Study

The results from Eli Lilly's Phase 3 trial of Donanemab showed that the drug significantly slowed cogntive and functional decline for early symptomatic Alzheimer's disease patients, decreasing their risk of disease progression. Their recent press release stated that "nearly half of participants at earlier stage of disease on donanemab had no clinical progression at 1 year".

This study demonstrates the importance of an early diagnosis and brings hope to people with Alzheimer's disease.

The Harvest Study

Are you a vegan or vegetarian woman, at least 18 years old, live within 40 miles of Norwich and in good health?

The Quadram institute are conducting a 17-week study to investigate the use of hydroponically-grown, biofertified salad greens, and use of a dietary app, on iron and B12 status in vegan or vegetarian women of child-bearing age.

BioIVT Acquires PrecisionMed, a Leading Global Provider of Biospecimens for Neurology and Oncology Research

PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced today that it has acquired PrecisionMed, LLC, a leading supplier of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics.

PrecisionLife Identifies First Detailed Genetic Risk Factors for Long COVID and Common Mechanisms with ME/CFS and other Complex Diseases

Oxford, UK, 18 July 2023 – PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients.

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer

Abzena Appoints Thomas Castellano as Chief Financial Officer

Abzena have announced the recent appointment of Thomas Castellano as Chief Financial Office (CFO). Abzena is a leading biopharmaceutical company headquartered at Babraham Research Research Campus in Cambridge, UK. Last year, they opened a new biologics testing laboratory in San Diego, near their Biologics process development and manufacturing hub.

Exploring Neurodegenerative Diseases in Microgravity

AMSBIO, a leading supplier of human cell lines and research tools, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments.

My Account